v3.26.1
Schedule of Company’s Segment (Details) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Segment Reporting [Line Items]      
Net Revenue $ 192,780  
Total Cost of Goods Sold 202,578  
Gross Margin (Loss) (9,798)  
Staking revenue, net 3,134,109  
Consulting fees – related parties 2,500,000  
Selling, general and administrative 5,053,320 1,364,295  
Research and development 137,097  
Unrealized loss on digital commodities 70,846,202  
Realized loss on digital commodities 10,789,841  
Digital commodity transaction expenses 63,821  
Total Operating Expenses 89,390,281 1,364,295  
Loss from Operations (86,265,970) (1,364,295)  
Fair market value adjustment on warrants 16,708 4,618,889  
Foreign currency loss (8)  
Other Income (Expense), net 26,738 3,991,898  
Income (Loss) Before Provision for Taxes (86,239,232) 2,627,603  
Tax Provision  
Income (Loss) from Continuing Operations (86,239,232) 2,627,603  
Income tax benefit (132,000)  
Net Income (Loss) (698,769)  
Assets 181,002,610   $ 269,075,173
Consolidated [Member]      
Segment Reporting [Line Items]      
Net Revenue 192,780  
Cost of goods sold 202,578  
Total Cost of Goods Sold 202,578  
Gross Margin (Loss) (9,798)  
Staking revenue, net 3,134,109  
Consulting fees – related parties 2,500,000  
Selling, general and administrative 5,053,320 1,364,296  
Research and development 137,097  
Unrealized loss on digital commodities 70,846,202  
Realized loss on digital commodities 10,789,841  
Digital commodity transaction expenses 63,821  
Total Operating Expenses 89,390,281 1,364,296  
Loss from Operations (86,265,970) (1,364,296)  
Interest expense, net 10,038 (626,991)  
Fair market value adjustment on warrants 16,708 4,618,889  
Foreign currency loss (8)  
Other Income (Expense), net 26,738 3,991,898  
Income (Loss) Before Provision for Taxes (86,239,232) 2,627,602  
Tax Provision  
Income (Loss) from Continuing Operations (86,239,232) 2,627,602  
Loss from discontinued operations (830,769)  
Income tax benefit 132,000  
Loss from Discontinued Operations (698,769)  
Net Income (Loss) (86,239,232) 1,928,833  
Assets 181,002,610   269,075,173
Operating Segments [Member] | Medical Device Packaging [Member]      
Segment Reporting [Line Items]      
Net Revenue 192,780  
Cost of goods sold 202,578  
Total Cost of Goods Sold 202,578  
Gross Margin (Loss) (9,798)  
Staking revenue, net  
Consulting fees – related parties  
Selling, general and administrative 175,488 427,082  
Research and development  
Unrealized loss on digital commodities  
Realized loss on digital commodities  
Digital commodity transaction expenses  
Total Operating Expenses 175,488 427,082  
Loss from Operations (185,286) (427,082)  
Interest expense, net  
Fair market value adjustment on warrants  
Foreign currency loss  
Other Income (Expense), net  
Income (Loss) Before Provision for Taxes (185,286) (427,082)  
Tax Provision    
Income (Loss) from Continuing Operations (185,286) (427,082)  
Loss from discontinued operations (830,769)  
Income tax benefit 132,000  
Loss from Discontinued Operations (698,769)  
Net Income (Loss) (185,286) (1,125,851)  
Operating Segments [Member] | Digital Assets [Member]      
Segment Reporting [Line Items]      
Net Revenue    
Cost of goods sold    
Total Cost of Goods Sold    
Gross Margin (Loss)    
Staking revenue, net 3,134,109    
Consulting fees – related parties 2,500,000    
Selling, general and administrative 438,209    
Research and development    
Unrealized loss on digital commodities 70,846,202    
Realized loss on digital commodities 10,789,841    
Digital commodity transaction expenses 63,821    
Total Operating Expenses 84,638,073    
Loss from Operations (81,503,964)    
Interest expense, net (19,229)    
Fair market value adjustment on warrants    
Foreign currency loss    
Other Income (Expense), net (19,229)    
Income (Loss) Before Provision for Taxes (81,523,193)    
Tax Provision    
Income (Loss) from Continuing Operations (81,523,193)    
Loss from discontinued operations    
Income tax benefit    
Loss from Discontinued Operations    
Net Income (Loss) (81,523,193)    
Assets 174,476,910   257,253,661
Operating Segments [Member] | Medical Device [Member]      
Segment Reporting [Line Items]      
Assets 516,543   849,388
Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]      
Segment Reporting [Line Items]      
Net Revenue  
Cost of goods sold  
Total Cost of Goods Sold  
Gross Margin (Loss)  
Staking revenue, net  
Consulting fees – related parties    
Selling, general and administrative 4,439,622 937,214  
Research and development 137,097  
Unrealized loss on digital commodities  
Realized loss on digital commodities  
Digital commodity transaction expenses  
Total Operating Expenses 4,576,719 937,214  
Loss from Operations (4,576,719) (937,214)  
Interest expense, net 29,267 (626,991)  
Fair market value adjustment on warrants 16,708 4,618,889  
Foreign currency loss (8)  
Other Income (Expense), net 45,967 3,991,898  
Income (Loss) Before Provision for Taxes (4,530,752) 3,054,684  
Tax Provision    
Income (Loss) from Continuing Operations (4,530,752) 3,054,684  
Loss from discontinued operations  
Income tax benefit  
Loss from Discontinued Operations  
Net Income (Loss) (4,530,752) $ 3,054,684  
Assets $ 6,009,157   $ 10,972,124